SCHEMBL1608867

SCHEMBL1608867

C1=NC=c2ccccc2=NC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL11809783 0.98
Hydrochloric Acid SCHEMBL11613916 0.98
SCHEMBL157942 0.72
SCHEMBL857888 0.68
SCHEMBL1249288 0.65
SCHEMBL16690908 0.63
SCHEMBL5050151 0.63
SCHEMBL5050144 0.63
SCHEMBL11443027 0.61
SCHEMBL19841379 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8492538-B1 Cyclodextrin derivative salts MATOS JOSE R (US) 2013-07-23 US claimed
CN-108303488-A The liquid phase chromatography analytical method of Clonazepam content in a kind of detection blood 北京和合医学诊断技术股份有限公司 2018-07-20 CN disclosed
US-20160272729-A1 METHOD OF TREATING A PATHOLOGICAL SYNDROME AND A PHARMACEUTICAL AGENT EPSHTEIN OLEG ILIICH (RU) 2016-09-22 US disclosed
US-20160229914-A1 METHOD OF TREATING A PATHOLOGICAL SYNDROME EPSHTEIN OLEG ILIICH (RU) 2016-08-11 US disclosed
US-9382332-B2 Method of treating a pathological syndrome and a pharmaceutical agent OLEG ILIICH EPSHTEIN (RU) 2016-07-05 US disclosed
US-20160184256-A1 METHOD OF TREATING DISORDERS OF THE CARDIOVASCULAR SYSTEM AND A PHARMACEUTICAL AGENT EPSHTEIN OLEG ILIICH (RU) 2016-06-30 US disclosed
US-20160176987-A1 METHOD OF TREATING A PATHOLOGICAL SYNDROME AND A PHARMACEUTICAL AGENT EPSHTEIN OLEG ILIICH (RU) 2016-06-23 US disclosed
US-20160137750-A1 METHOD OF TREATING A PATHOLOGICAL SYNDROME EPSHTEIN OLEG IIIICH (RU) 2016-05-19 US disclosed
US-9303091-B2 Method of treating disorders of the cardiovascular system and a pharmaceutical agent Epshtein, Oleg Iliich (RU) 2016-04-05 US disclosed
US-9303090-B2 Method of treating a pathological syndrome and a pharmaceutical agent Epshtein, Oleg Iliich (RU) 2016-04-05 US disclosed
US-20100166762-A1 METHOD OF TREATING A PATHOLOGICAL SYNDROME Epshtein, Oleg Iliich (RU) 2010-07-01 US disclosed
US-20080131440-A1 Method of treating a pathological syndrome and a pharmaceutical agent Epshtein, Oleg I. (RU) 2008-06-05 US disclosed
US-20080050360-A1 Method of treating a pathological syndrome and a pharmaceutical agent EPSHTEIN, OLEG I. (RU) 2008-02-28 US disclosed
US-20080050392-A1 Method of treating a pathological syndrome and a pharmaceutical agent ILIICH EPSHTEIN O 2008-02-28 US disclosed
US-20080025985-A1 Method of treating a pathological syndrome and a pharmaceutical agent EPSHTEIN, OLEG I. (RU) 2008-01-31 US disclosed
US-20080019982-A1 Method of treating a pathological syndrome and a pharmaceutical agent EPSHTEIN, OLEG I. (RU) 2008-01-24 US disclosed
US-20070224187-A1 Method of treating a pathological syndrome and a pharmaceutical agent EPSHTEIN, OLEG I. (RU) 2007-09-27 US disclosed
US-20030099636-A1 Curing method for pathologic syndrome and medicinal preparation EPSHTEIN, OLEG I. (RU) 2003-05-29 US disclosed
EP-1295606-A1 CURING METHOD FOR PATHOLOGIC SYNDROME AND A MEDICINAL PREPARATION Epshtein, Oleg Iliich (RU) 2003-03-26 EP disclosed
US-4082761-A CENTRAL NERVOUS SYSTEM DEPRESSANTS THE UPJOHN COMPANY (US) 1978-04-04 US disclosed